The Discovery of Novel PGK1 Activators as Apoptotic Inhibiting and Neuroprotective Agents

Stroke is the second leading cause of death worldwide and the leading cause of long-term disability that seriously endangers health and quality of human life. Tissue-type fibrinogen activator is currently the only drug approved by FDA for the treatment of ischemic stroke. Neuroprotection is theoreti...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiang, Shao-Jia, Shi, Yu-Qi, Wu, Tong-Yu, Wang, Jing-Quan, Chen, Xue-Lian, Su, Jie, Chen, Xin-Ping, Li, Jia-Zhong, Chen, Zhe-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978560/
https://www.ncbi.nlm.nih.gov/pubmed/35387336
http://dx.doi.org/10.3389/fphar.2022.877706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978560/
https://www.ncbi.nlm.nih.gov/pubmed/35387336
http://dx.doi.org/10.3389/fphar.2022.877706

Ejemplares similares